Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products.
Saito KI, Inoue Y, Ikegami Y, Nanbo I, Onozuka M, Sano K, Yoshida H, Sakamoto T, Tatebayashi E, Fujita KI, Sasaki Y, Kitazawa T.
Saito KI, et al. Among authors: onozuka m.
Anticancer Res. 2016 Nov;36(11):5957-5963. doi: 10.21873/anticanres.11183.
Anticancer Res. 2016.
PMID: 27793921